BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8856256)

  • 21. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .
    Kitamura M; Sütö T; Yokoo T; Shimizu F; Fine LG
    J Immunol; 1996 Apr; 156(8):2964-71. PubMed ID: 8609417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
    Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
    J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase production of fibronectin by glomerular cultures from rats with nephrotoxic nephritis. Macrophages induce fibronectin production in cultured mesangial cells.
    Mosquera JA
    Lab Invest; 1993 Apr; 68(4):406-12. PubMed ID: 8479148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGF-beta- and angiotensin-II-induced mesangial matrix protein secretion is mediated by protein kinase C.
    Weiss RH; Ramirez A
    Nephrol Dial Transplant; 1998 Nov; 13(11):2804-13. PubMed ID: 9829482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol feeding activates macrophages to upregulate rat mesangial cell fibronectin production.
    Pawluczyk IZ; Harris KP
    Nephrol Dial Transplant; 2000 Feb; 15(2):161-6. PubMed ID: 10648660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta.
    López-Armada MJ; Gómez-Guerrero C; Egido J
    J Immunol; 1996 Sep; 157(5):2136-42. PubMed ID: 8757338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth abnormalities in cultured mesangial cells from rats with spontaneous glomerulosclerosis.
    Pugliese F; Ferrario RG; Ciavolella A; Tamburin M; Benatti L; Casini A; Patrono C; Salvati P
    Kidney Int; 1995 Jan; 47(1):106-13. PubMed ID: 7731135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of alpha1beta1 integrin directly affects rat mesangial cell behavior.
    Kagami S; Kondo S; Urushihara M; Löster K; Reutter W; Saijo T; Kitamura A; Kobayashi S; Kuroda Y
    Kidney Int; 2000 Sep; 58(3):1088-97. PubMed ID: 10972673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor-1 stimulates production of mesangial cell matrix components.
    Schreiber BD; Hughes ML; Groggel GC
    Clin Nephrol; 1995 Jun; 43(6):368-74. PubMed ID: 7554520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells.
    Pugliese G; Pricci F; Pugliese F; Mene P; Lenti L; Andreani D; Galli G; Casini A; Bianchi S; Rotella CM
    Diabetes; 1994 Mar; 43(3):478-90. PubMed ID: 8314022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of high glucose concentration on angiotensin II- or transforming growth factor-beta-induced DNA synthesis, hypertrophy and collagen synthesis in cultured rat mesangial cells.
    Choi KH; Kang SW; Lee HY; Han DS
    Yonsei Med J; 1996 Oct; 37(5):302-11. PubMed ID: 8997162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production.
    Pugliese G; Pricci F; Locuratolo N; Romeo G; Romano G; Giannini S; Cresci B; Galli G; Rotella CM; Di Mario U
    Diabetologia; 1996 Jul; 39(7):775-84. PubMed ID: 8817101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of nodular sclerosis by insulin in rat mesangial cells in vitro: studies of collagen.
    Abrass CK; Spicer D; Raugi GJ
    Kidney Int; 1995 Jan; 47(1):25-37. PubMed ID: 7731154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
    Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
    J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis.
    Oh JH; Ha H; Yu MR; Lee HB
    Kidney Int; 1998 Dec; 54(6):1872-8. PubMed ID: 9853252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo transfer of engineered macrophages into the glomerulus: endogenous TGF-beta-mediated defense against macrophage-induced glomerular cell activation.
    Sütö TS; Fine LG; Shimizu F; Kitamura M
    J Immunol; 1997 Sep; 159(5):2476-83. PubMed ID: 9278341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta suppresses macrophage-induced mesangial cell fibronectin expression.
    Pawluczyk IZ; Harris KP
    Kidney Int; 2001 Aug; 60(2):533-42. PubMed ID: 11473636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.
    Kagami S; Border WA; Miller DE; Noble NA
    J Clin Invest; 1994 Jun; 93(6):2431-7. PubMed ID: 8200978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesangial cell-matrix interactions: modulation of matrix expression in mesangial cells by extracellular matrices.
    Sakatsume M; Saito A; Takeda T; Yamazaki H; Narita I; Nishi S; Nakagawa Y; Arakawa M
    Exp Nephrol; 1995; 3(6):362-8. PubMed ID: 8528681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.